Search PubMed⌕ Search

PubMed · 11030632

Miniscopes.

Abstract

Various miniscopes are available for cholangioscopy and pancreatoscopy, differing in the size of the external diameter and the instrumentation channel, the angulation system and the optical performance. For the per-oral route, the devices are inserted through a carrier duodenoscope. Ultra-thin instruments can be introduced into the biliopancreatic tract without the need for endoscopic sphincterotomy. Larger and steerable miniscopes are required for target biopsies and the approach to proximal lesions. Percutaneous cholangioscopy is more invasive and should be restricted to cases with a difficult anatomy or intrahepatic biliary disease. These techniques can be useful for the diagnosis of lesions that cannot be differentiated by indirect imaging methods. However, further studies are needed to evaluate their impact on clinical outcome. Controlled trials indicate that cholangioscopic lithotripsy is an effective and rapid alternative to other therapeutic methods for difficult bile duct stones. Mini-endoscopy is restricted to specific centres because of the high costs of the instruments, limited indications and the need for special endoscopic expertise.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Neuhaus, B Schumacher. 1999. Miniscopes.. https://doi.org/10.1053/bega.1999.0006

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.

The tumor-suppressor genes p14(ARF), p16(INK4a) and Tp53 are commonly inactivated in many tumors. We investigated their role in the pathogenesis of 9 bile tract cancer cell lines and 21 primary sporadic extrahepatic bile duct carcinomas. p53 and p16 protein expression was examined by Western blot analysis and immunohistochemistry. Mutation screening of p53 was done by SSCP and direct sequencing. Inactivating mechanisms of p14 and p16 were addressed by screening for mutations, homozygous deletions, chromosomal loss of 9p21 (loss of heterozygosity [LOH] analysis) and promoter hypermethylation of the p14/p16 genes. p53 overexpression could be detected in 7 of 9 cell lines and 7 of 21 primary tumors, but mutations were found in 3 cell lines only. p16 expression was absent in all cell lines, due to homozygous deletion of the gene in 8 of 9 cell lines and hypermethylation of the p16 promoter in one cell line (CC-LP-1). p14 exon 1beta was homozygously deleted in 6 of 9 cell lines, while retained in CC-LP-1 and 2 additional lines. No p14 promoter hypermethylation could be detected. p16 expression was lost in 11 of 21 primary tumors. p16 promoter hypermethylation was present in 9 of 21 primary tumors, all with lost p16 expression. Allelic loss at 9p21 was detected in 13 of 21 primary tumors, 10 of 11 with lost p16 expression and 8 of 9 with methylated p16 promoter. No p14 promoter hypermethylation or p14/p16 mutations could be detected. Neither Tp53 nor p16 alterations showed obvious association with histopathologic or clinical characteristics. In conclusion, inactivation of the p16 gene is a frequent event in primary sporadic extrahepatic bile duct cancers, 9p21 LOH and promoter hypermethylation being the principal inactivating mechanisms. Therefore, p16, but not p14, seems to be the primary target of inactivation at the INK4a locus in bile duct cancers. Other mechanisms than Tp53 mutations seems to be predominantly responsible for stabilization of nuclear p53 protein in bile duct cancers.

Bile Duct Neoplasms↗

[Diagnostics and treatment of distal bile duct or pancreatic carcinoma; guidelines of the Amsterdam and Twente Comprehensive Cancer Centers].

A project on the diagnostic work-up and treatment of distal bile duct and pancreatic carcinoma was carried out in the region covered by the Comprehensive Cancer Centre in Amsterdam, the Netherlands. It consisted of (a) describing the diagnostic work-up in the area, (b) developing the guidelines, (c) spreading the recommendations. The implementation and application of the guidelines are currently being evaluated.

Bile Duct Neoplasms↗